Category
Services
Modalities
Indications
Phases
Sourcing
Locations
Certifications
Discovery Research, Target Identification & Validation, High-Throughput Screening, Medicinal Chemistry, Computational & In-Silico Drug Discovery, Protein Engineering, Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Genetic Toxicology, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Carcinogenicity Studies, DART (Reproductive & Developmental Toxicology), Specialized & Large-Animal Models, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Immunogenicity Assays (ADA / NAb), Biomarker Assays, Flow Cytometry Services, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Analytical Method Development & Validation, ICH Stability Studies, Translational Research
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Antibody-Drug Conjugate (ADC), Oligonucleotide, mRNA, Cell Therapy, Gene Therapy, Peptide, Vaccine
Oncology, Immunology, Neurology, Psychiatry, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Discovery, Preclinical (General), Preclinical (IND-Enabling), Phase I, Phase II, Phase III, Phase IV
Full-Service Outsourcing (FSO)
Headquarters, Shanghai, Pudong, China, Global Operations, Asia, Europe, North America
—
Discovery Research, Target Identification & Validation, High-Throughput Screening, Medicinal Chemistry, Computational & In-Silico Drug Discovery, Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Genetic Toxicology, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Biomarker Assays, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Medical Writing, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Translational Research
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Antibody-Drug Conjugate (ADC), Oligonucleotide, mRNA, Cell Therapy, Gene Therapy, Peptide, Vaccine
Oncology, Immunology, Neurology, Psychiatry, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Discovery, Preclinical (General), Phase I, Phase II, Phase III, Phase IV, Preclinical (IND-Enabling), Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Global network, Global presence, 30 countries, Global presence, Multiple, 30 countries, Global, Global presence, Multiple, 30+ countries, Global presence, Multiple, 30 countries, International, Headquarters, Radnor, Pennsylvania, United States, Global presence, 30 countries, Global presence, 30+ countries
—
Discovery Research, Target Identification & Validation, High-Throughput Screening, Medicinal Chemistry, Computational & In-Silico Drug Discovery, Protein Engineering, Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Genetic Toxicology, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Carcinogenicity Studies, DART (Reproductive & Developmental Toxicology), Specialized & Large-Animal Models, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Immunogenicity Assays (ADA / NAb), Biomarker Assays, Flow Cytometry Services, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Analytical Method Development & Validation, ICH Stability Studies, Translational Research
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Antibody-Drug Conjugate (ADC), Oligonucleotide, mRNA, Cell Therapy, Gene Therapy, Peptide, Vaccine
Oncology, Immunology, Neurology, Psychiatry, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Discovery, Preclinical (General), Preclinical (IND-Enabling)
Full-Service Outsourcing (FSO)
Global Headquarters, Hyderabad, Telangana, India, R&D and Manufacturing Campus, Hyderabad, Telangana, India, R&D Campus, Hyderabad, Telangana, India, Manufacturing Campus, Visakhapatnam, Andhra Pradesh, India, R&D Campus, Bengaluru, Karnataka, India, Biosafety Solutions, Pune, Maharashtra, India, Regional Office, New Delhi, Delhi, India, Sales Office, Tokyo, Japan, Sales Office, Seoul, South Korea, Sales Office, Cambridge, Massachusetts, USA, R&D Campus, Morgan Hill, California, USA, Sales Office, Utrecht, Netherlands, Sales Office, Milan, Italy, Sales Office, South Korea, Global Headquarters & R&D and Manufacturing Campus, Hyderabad, Telangana, India, R&D Campus, Pune, Maharashtra, India, R&D Campus, New Delhi, Delhi, India, Sales Office, New Jersey, New Jersey, USA, Global Headquarters, R&D and Manufacturing Campus, Hyderabad, Telangana, India, R&D Campus, Mallapur, Hyderabad, India
USFDA · ID: EIR for Nacharam Unit 1
Discovery Research, Target Identification & Validation, High-Throughput Screening, Medicinal Chemistry, Computational & In-Silico Drug Discovery, Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Genetic Toxicology, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, DART (Reproductive & Developmental Toxicology), Specialized & Large-Animal Models, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Immunogenicity Assays (ADA / NAb), Biomarker Assays, Flow Cytometry Services, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Medical Writing, Central Laboratory Services, Regulatory Affairs, US FDA Regulatory Strategy, Analytical Method Development & Validation, ICH Stability Studies, Pathology & Histology Services, Genomics & Sequencing Services
Small Molecule, Biologics (Monoclonal Antibodies), Antibody-Drug Conjugate (ADC), Cell Therapy, Gene Therapy
Oncology
Discovery, Preclinical (General), Preclinical (IND-Enabling), Phase I, Phase II
Full-Service Outsourcing (FSO)
Headquarters, Global Operations
FDA · ID: 200+ FDA Inspections
Showing three peers in the matrix — full ranked list is above.